(Q33392225)

English

Efficacy and safety of rituximab in adult patients with idiopathic relapsing or refractory thrombotic thrombocytopenic purpura: results of a Spanish multicenter study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Efficacy and safety of rituximab in adult patients with idiopathic relapsing or refractory thrombotic thrombocytopenic purpura: results of a Spanish multicenter study (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

0 references

multicenter clinical trial

0 references

thrombocytopenia

1 reference

based on heuristic

inferred from title

thrombotic thrombocytopenic purpura

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Javier de la Rubia

object named as

Javier de la Rubia

1

0 references

object named as

Miguel A Sanz

15

0 references

author name string

Federico Moscardó

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

María J Gómez

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Ramón Guardia

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Pilar Rodríguez

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Ana Sebrango

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Concepción Zamora

7

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Guillermo Debén

8

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Rosa Goterris

9

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Rafaela López

10

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Francisco Peña

11

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Misericordia Pujol

12

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Antonio Vidaller

13

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Julio Del Río-Garma

14

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Grupo Español de Aféresis

16

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

publication date

12 October 2010

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Transfusion and Apheresis Science

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

43

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

299-303

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Clinical practice. Thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2010.09.018

7 January 2021

Journey in reverse: TTP from bedside to blood bank to bench

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2010.09.018

7 January 2021

Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2010.09.018

7 January 2021

Thrombotic thrombocytopenic purpura and its diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2010.09.018

7 January 2021

Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2010.09.018

7 January 2021

Splenectomy for the treatment of thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2010.09.018

7 January 2021

Vincristine for thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2010.09.018

7 January 2021

Vincristine for thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2010.09.018

7 January 2021

Ineffectiveness of high-dose intravenous gammaglobulin infusion in thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2010.09.018

7 January 2021

Cyclophosphamide for chronic relapsing thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2010.09.018

7 January 2021

Splenectomy done during hematologic remission to prevent relapse in patients with thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2010.09.018

7 January 2021

Rituximab in the treatment of autoimmune haematological disorders

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2010.09.018

7 January 2021

Efficiency of curative and prophylactic treatment with rituximab in ADAMTS13-deficient thrombotic thrombocytopenic purpura: a study of 11 cases

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2010.09.018

7 January 2021

Remission in acute refractory and relapsing thrombotic thrombocytopenic purpura following rituximab is associated with a reduction in IgG antibodies to ADAMTS-13.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2010.09.018

7 January 2021

Methylene blue-photoinactivated plasma versus quarantine fresh frozen plasma in thrombotic thrombocytopenic purpura: a multicentric, prospective cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2010.09.018

7 January 2021

Advances in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2010.09.018

7 January 2021

Complications of plasma exchange in patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2010.09.018

7 January 2021

Rituximab therapy for refractory thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2010.09.018

7 January 2021

Recent advances in thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2010.09.018

7 January 2021

Late relapses in patients successfully treated for thrombotic thrombocytopenic purpura. Canadian Apheresis Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2010.09.018

7 January 2021

Combination vincristine and plasma exchange as initial therapy in patients with thrombotic thrombocytopenic purpura: one institution's experience and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2010.09.018

7 January 2021

Cardiogenic shock complicates successful treatment of refractory thrombotic thrombocytopenia purpura with rituximab

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2010.09.018

7 January 2021

Identifiers

10.1016/J.TRANSCI.2010.09.018

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33392225&oldid=1561100539"